D1-like dopamine receptors antagonist inhibits cutaneous immune reactions mediated by Th2 and mast cells. 2013

Tomoko Mori, and Kenji Kabashima, and Shoko Fukamachi, and Etsushi Kuroda, and Jun-ichi Sakabe, and Miwa Kobayashi, and Saeko Nakajima, and Kazuhisa Nakano, and Yoshiya Tanaka, and Sho Matsushita, and Motonobu Nakamura, and Yoshiki Tokura
Department of Dermatology, University of Occupational and Environmental Health, Kitakyusyu, Japan. tomoko-n@med.uoeh-u.ac.jp

BACKGROUND Dopamine transduces signals via five subtypes of G protein-coupled receptors. Among these subtypes, the D1 and D5 receptors belong to the D1-like group. Although dopamine is known to mediate immune responses, its involvement in cutaneous immunity remains unclear. OBJECTIVE The aim of this study is to determine the role of dopamine and its D1-like receptors in cutaneous immune responses. METHODS By using the D1-like receptor antagonist SCH 23390, we examined the role of D1-like receptors in murine models of Th1-type contact hypersensitivity and Th2-type atopic dermatitis in vivo, and in mast cells and Th2 cell differentiation in vitro. RESULTS Administration of SCH 23390 did not affect Th1-type contact hypersensitivity but suppressed the immediate-type reaction (ITR) and the late phase reaction (LPR) in the atopic dermatitis model. In addition, SCH 23390-treated mice showed higher IFN-γ and lower IL-4 mRNA levels in the ear skin of challenged mice than did non-treated mice as analyzed by real-time RT PCR. Consistently, the passive cutaneous anaphylaxis reaction was significantly reduced in SCH 23390-treated mice. Moreover, dopamine enhanced mast cell degranulation and Th2 cell differentiation, and both activities were abrogated by SCH 23390. CONCLUSIONS These findings suggest that the D1-like receptors mediate immediate and late phase skin reactions by promoting Th2 induction and mast cell degranulation.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008407 Mast Cells Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR. Basophils, Tissue,Basophil, Tissue,Cell, Mast,Cells, Mast,Mast Cell,Tissue Basophil,Tissue Basophils
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003876 Dermatitis, Atopic A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. Eczema, Atopic,Eczema, Infantile,Neurodermatitis, Atopic,Neurodermatitis, Disseminated,Atopic Dermatitis,Atopic Eczema,Atopic Neurodermatitis,Disseminated Neurodermatitis,Infantile Eczema
D003877 Dermatitis, Contact A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms. Contact Dermatitis,Dermatitis Venenata,Eczema, Contact,Hypersensitivity, Contact,Sensitivity, Contact,Contact Dermatitides,Contact Eczema,Contact Hypersensitivities,Contact Hypersensitivity,Contact Sensitivities,Contact Sensitivity,Dermatitides, Contact,Hypersensitivities, Contact,Sensitivities, Contact
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression

Related Publications

Tomoko Mori, and Kenji Kabashima, and Shoko Fukamachi, and Etsushi Kuroda, and Jun-ichi Sakabe, and Miwa Kobayashi, and Saeko Nakajima, and Kazuhisa Nakano, and Yoshiya Tanaka, and Sho Matsushita, and Motonobu Nakamura, and Yoshiki Tokura
January 2024, Biological & pharmaceutical bulletin,
Tomoko Mori, and Kenji Kabashima, and Shoko Fukamachi, and Etsushi Kuroda, and Jun-ichi Sakabe, and Miwa Kobayashi, and Saeko Nakajima, and Kazuhisa Nakano, and Yoshiya Tanaka, and Sho Matsushita, and Motonobu Nakamura, and Yoshiki Tokura
January 2019, JCI insight,
Tomoko Mori, and Kenji Kabashima, and Shoko Fukamachi, and Etsushi Kuroda, and Jun-ichi Sakabe, and Miwa Kobayashi, and Saeko Nakajima, and Kazuhisa Nakano, and Yoshiya Tanaka, and Sho Matsushita, and Motonobu Nakamura, and Yoshiki Tokura
May 2011, Journal of immunology (Baltimore, Md. : 1950),
Tomoko Mori, and Kenji Kabashima, and Shoko Fukamachi, and Etsushi Kuroda, and Jun-ichi Sakabe, and Miwa Kobayashi, and Saeko Nakajima, and Kazuhisa Nakano, and Yoshiya Tanaka, and Sho Matsushita, and Motonobu Nakamura, and Yoshiki Tokura
July 2019, Journal of neuroimmunology,
Tomoko Mori, and Kenji Kabashima, and Shoko Fukamachi, and Etsushi Kuroda, and Jun-ichi Sakabe, and Miwa Kobayashi, and Saeko Nakajima, and Kazuhisa Nakano, and Yoshiya Tanaka, and Sho Matsushita, and Motonobu Nakamura, and Yoshiki Tokura
January 1986, Advances in experimental medicine and biology,
Tomoko Mori, and Kenji Kabashima, and Shoko Fukamachi, and Etsushi Kuroda, and Jun-ichi Sakabe, and Miwa Kobayashi, and Saeko Nakajima, and Kazuhisa Nakano, and Yoshiya Tanaka, and Sho Matsushita, and Motonobu Nakamura, and Yoshiki Tokura
January 2015, Frontiers in immunology,
Tomoko Mori, and Kenji Kabashima, and Shoko Fukamachi, and Etsushi Kuroda, and Jun-ichi Sakabe, and Miwa Kobayashi, and Saeko Nakajima, and Kazuhisa Nakano, and Yoshiya Tanaka, and Sho Matsushita, and Motonobu Nakamura, and Yoshiki Tokura
September 2011, Journal of neurochemistry,
Tomoko Mori, and Kenji Kabashima, and Shoko Fukamachi, and Etsushi Kuroda, and Jun-ichi Sakabe, and Miwa Kobayashi, and Saeko Nakajima, and Kazuhisa Nakano, and Yoshiya Tanaka, and Sho Matsushita, and Motonobu Nakamura, and Yoshiki Tokura
January 2020, Frontiers in pharmacology,
Tomoko Mori, and Kenji Kabashima, and Shoko Fukamachi, and Etsushi Kuroda, and Jun-ichi Sakabe, and Miwa Kobayashi, and Saeko Nakajima, and Kazuhisa Nakano, and Yoshiya Tanaka, and Sho Matsushita, and Motonobu Nakamura, and Yoshiki Tokura
October 1992, Neuroreport,
Tomoko Mori, and Kenji Kabashima, and Shoko Fukamachi, and Etsushi Kuroda, and Jun-ichi Sakabe, and Miwa Kobayashi, and Saeko Nakajima, and Kazuhisa Nakano, and Yoshiya Tanaka, and Sho Matsushita, and Motonobu Nakamura, and Yoshiki Tokura
October 2019, American journal of physiology. Renal physiology,
Copied contents to your clipboard!